No abstract

No abstract

BaCKgRoUND aND aIMS: Early recurrence of hepatocellular carcinoma (HCC) after surgical resection compromises patient survival. Timely detection of HCC recurrence and its clonality is required to implement salvage therapies appropriately. This study examined the feasibility of virus-host chimera DNA (vh-DNA), generated from junctions of hepatitis B virus (HBV) integration in the HCC chromosome, as a circulating biomarker for this clinical setting. appRoaCH aND ReSUltS: HBV integration in 50 patients with HBV-related HCC was determined by the Hybridization capture-based next-generation sequencing (NGS) platform. For individual HCC, the vh-DNA was quantified by specific droplet digital PCR (ddPCR) assay in plasma samples collected before and 2 months after surgery. HBV integrations were identified in 44 out of 50 patients with HBV-related HCC. Tumor-specific ddPCR was developed to measure the corresponding vh-DNA copy number in baseline plasma from each patient immediately before surgery. vh-DNA was detected in 43 patients (97.7%), and the levels correlated with the tumor sizes (detection limit at 1.5 cm). Among the plasma collected at 2 months after surgery, 10 cases (23.3%) still contained the same signature vh-DNA detected at baseline, indicating the presence of residual tumor cells. Nine of them (90%) experienced HCC recurrence within 1 year, supporting vh-DNA as an independent risk factor in predicting early recurrence. Analysis of circulating vh-DNA at recurrence further helped identify the clonal origin. A total of 81.8% of recurrences came from original HCC clones sharing the same plasma vh-DNA, whereas 18.2% were from de novo HCC. CoNClUSIoNS: vh-DNA was shown to be a circulating biomarker for detecting the tumor load in majority of patients with HBV-related HCC and aided in monitoring residual tumor and recurrence clonality after tumor resection. (Hepatology 2020;72:2063-2076). S urgical resection has been recommended for earlystage hepatocellular carcinoma (HCC) when the liver function is well preserved. (1) Although the clinical outcome is improved after resection, these patients still confront high risk for recurrent HCC, at a rate of about 40%-50% within 2 years. (2) Recurrence after resection, especially those that recur within 1 year, significantly decreases the survival of patients with HCC. Early recurrence after tumor resection, possibly originating from residual HCC, thus compromises the long-term prognosis.

Melt state properties of nylon-11 and its exfoliated silicate nanocomposite were monitored during extrusion compounding using an on-line dielectric slit die sensor, and solid-state properties were probed off-line below the melting temperature by a dielectric spectrometer. A comprehensive relaxation master map for nylon-11 and its exfoliated clay nanocomposite featuring six relaxation modes in both melt and semicrystalline states revealed changes in molecular dynamics upon the addition of nanofillers. α relaxation was observed in the neat resin as well as the composite, and a Maxwell−Wagner−Sillars (MWS) relaxation was detected in the composite melt yet absent from the neat molten nylon. The MWS relaxation mode, which exhibited a broader relaxation time distribution and a much greater dielectric intensity compared to the α relaxation, resulted from polarization at the filler/polymer interfaces. MWS can be used to distinguish the neat polymer from the composite during real-time processing. The presence of exfoliated clay particles accelerated the α relaxation dynamics in the semicrystalline state as delaminated silicate platelets diminished the intermolecular cooperativity of the amorphous chains. Randomization of molecular dipoles upon increasing temperature was only observed in the neat nylon. Hindered molecular dipole orientation due to the rigid silicate fillers in the nanocomposite was observed.

No abstract